Browse current and previous editions of Switzer Report
This week on Boom Doom Zoom, Paul Rickard and Peter Switzer tackle a market that’s rotating aggressively. Banks are back in favour. Resources are surging. Healthcare and SaaS names? Getting smashed.
Here are three stocks positioned nicely to bring gas to hungry markets. These are unprofitable, speculative stocks – with attractive potential attributes – so, as always, do your own homework!
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, notes that Morgans has added Pro Medicus (PME) to the Best Ideas List.
Seven magnificent tech giants have powered the rise of the US stock market. They’re now a tick over a third of the benchmark US S&P 500 index. This year they’re off to a mixed start. If you’re concerned you might have too much exposure to them, here are some index tracking ETFs to consider.
For the week ending Friday 6th February 2026, FNArena tracked 23 upgrades and 14 downgrades for ASX-listed companies from brokers monitored daily.
Today I’m standing on the shoulders of great business builders to argue that this tech sell off is a buying opportunity. Stay with me on this!
Australian tech stocks have taken a brutal hit — but is the sell-off finally over?
Even before Friday’s incredible U-turn for stocks, where the Dow Jones was up a huge 1,000 points plus (with even the recently hated tech stocks back in favour), I had used the headline that it was a crazy week, and Donald Trump wasn’t to blame.
Contrary to media speculation, I can’t see the case for three rate rises this year. If I’m right, REITs could be among the more interesting investment ideas in 2026.
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains why at its current price Worley (WOR) is a buy.
Boom Doom Zoom was back live this week with plenty for investors to chew over, as markets juggle a hot resources trade, a bruised tech sector and growing questions around global growth.
Why should I invest in an “equal-weighted” ETF such as QUS rather than a “market cap” weighted ETF such as IVV? With all the chat about SaS firms being “wiped out” by AI, do the major brokers still see considerable upside for Xero? Why is Amcor’s dividend of 5.8% unfranked? Are there any term deposits paying 5.0% yet?
I’m taking the long-term punt on these three quality plays that have been beaten up big time of late
In this article, we look at how our model portfolios have performed so far in 2026.
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk explains why Morgans regards ResMed (RMD) as a BUY.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.